| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |